Enobosarm

Generic Name
Enobosarm
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H14F3N3O3
CAS Number
841205-47-8
Unique Ingredient Identifier
O3571H3R8N
Background

Enobosarm has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt

Phase 2
Active, not recruiting
Conditions
Muscle Loss
Obesity
Interventions
Drug: Enobosarm
Drug: Semaglutide
First Posted Date
2024-02-28
Last Posted Date
2024-08-09
Lead Sponsor
Veru Inc.
Target Recruit Count
150
Registration Number
NCT06282458
Locations
🇺🇸

SKY Integrative Medical Center, Ridgeland, Mississippi, United States

🇺🇸

Artemis Institute for Clinical Research, San Diego, California, United States

🇺🇸

Palm Research Center, Las Vegas, Nevada, United States

and more 11 locations

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Phase 3
Terminated
Conditions
Metastatic Breast Cancer
Interventions
Drug: Enobosarm
Drug: Exemestane
First Posted Date
2021-05-03
Last Posted Date
2024-01-26
Lead Sponsor
Veru Inc.
Target Recruit Count
52
Registration Number
NCT04869943
Locations
🇺🇸

Banner Health/ Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

🇺🇸

Texas Oncology Sammons Cancer Center, Dallas, Texas, United States

🇺🇸

University of Miami- Sylvester Comprehensive Cancer Center, Miami, Florida, United States

and more 50 locations

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Phase 1
Completed
Conditions
Mammographic Density
Interventions
Drug: enobosarm
First Posted Date
2017-08-29
Last Posted Date
2018-04-18
Lead Sponsor
Havah Therapeutics Pty Ltd
Target Recruit Count
9
Registration Number
NCT03264651
Locations
🇦🇺

Wellend Health, Toorak Gardens, South Australia, Australia

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

First Posted Date
2016-11-23
Last Posted Date
2024-02-20
Lead Sponsor
City of Hope Medical Center
Target Recruit Count
18
Registration Number
NCT02971761
Locations
🇺🇸

City of Hope West Covina, West Covina, California, United States

🇺🇸

City of Hope Medical Center, Duarte, California, United States

🇺🇸

City of Hope Mission Hills, Mission Hills, California, United States

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy